Key points are not available for this paper at this time.
Design
Review
No takes yet. Share an insight, caveat, or question.
May refine hypertension risk stratification beyond standard markers; leaves open prospective validation before clinical use.
Izzard et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: